Dietary supplements in the treatment of nucleoside reverse transcriptase inhibitor-related mitochondrial toxicity [4]

AIDS

Volumn 16, Issue 5, 2002, Pages 800-802

  Venhoff, Nils ^a   Setzer, Bernhard ^a   Lebrecht, Dirk ^a   Walker, Ulrich A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; RIBOFLAVIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIAMINE; ZALCITABINE;

ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA REPLICATION; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MITOCHONDRIAL MYOPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-HIV AGENTS; ASCORBIC ACID; CARNITINE; CELL SURVIVAL; DIETARY SUPPLEMENTS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; HUMANS; LACTIC ACID; LIPID METABOLISM; MITOCHONDRIA; NUCLEOSIDES; RIBOFLAVIN; RNA-DIRECTED DNA POLYMERASE; THIAMINE; TUMOR CELLS, CULTURED; ZALCITABINE;

EID: 0037192589     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203290-00021     Document Type: Letter

References (6)

1. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
2. Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis
3. The therapy of respiratory chain encephalomyopathy: A critical review of the past and current perspective
4. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins
5. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice
6. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection